Metabolism-Targeted Therapy Decreases Proliferation and Migration in CRC-Derived Cells by Modulating Wnt/β-Catenin Signaling Pathway
: Background: Colorectal cancer (CRC) is the second most frequent cancer in women and the third most frequent in men. Current therapeutic approaches, including surgery, chemotherapy, and targeted therapy, often exhibit limited specificity and are associated with substantial adverse effects, compromising patient outcome...